The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients
The Influence of Android Application as a Pharmaceutical Education Tool on Knowledge, Adherence, Clinical Outcome and Quality of Life of Hypertension Prolanis Patients: A Pilot Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Lampung
-
Bandar Lampung, Lampung, Indonesia
- Health Centers
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients aged ≥ 18 years, male and female who are willing to be respondents.
- Patients diagnosed with hypertension or currently taking ≥ 1 antihypertensive drug.
- Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.
- Not illiterate and owns a smartphone.
- Patients who are willing to participate in the study by signing an informed consent.
Exclusion Criteria:
- Physical and mental disabilities such as deaf, blind, and psychiatric disorders.
- The patient is pregnant
- Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Intervention group
Pharmacy Education with Android Application as a Tool Conducted for Three Months in Hypertensive Patients to Improve Knowledge, Adherence, Outcome Therapy and Quality of Life
|
Android Application for 3 months
Pharmacy education in hypertensive patients
|
|
Active Comparator: Pharmacy education
Pharmacy education in hypertensive patients
|
Pharmacy education in hypertensive patients
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge about hypertension
Time Frame: At day 90 after treatment
|
Measured by Hypertension Knowledge-Level Scale (HK-LS) questionnaires
|
At day 90 after treatment
|
|
Adherence to antihypertensive treatment
Time Frame: At day 90 after treatment
|
Measurement by Medication Adherence Report Scale (MARS) questionnaires
|
At day 90 after treatment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure
Time Frame: 90 days
|
Measurement by blood pressure measuring device.
|
90 days
|
|
Quality of life related to the health
Time Frame: 90 days
|
Measurement by Short Form-36 (SF-36) questionnaires
|
90 days
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Abdul K Tasib, S.Si., Apt., Faculty of Pharmacy Universitas Padjadjaran Bandung
- Principal Investigator: Eli Halimah, Dr.M.Si.Apt., Faculty of Pharmacy Universitas Padjadjaran Bandung
- Principal Investigator: Irma M Puspitasari, Prof.MT.Ph.D, Faculty of Pharmacy Universitas Padjadjaran Bandung
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Pharm-202301.01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.